These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 35696066)

  • 21. Relationship between pre-existing allergies and anaphylactic reactions post mRNA COVID-19 vaccine administration.
    Desai AP; Desai AP; Loomis GJ
    Vaccine; 2021 Jul; 39(32):4407-4409. PubMed ID: 34215453
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Allergic Reactions After the Administration of COVID-19 Vaccines.
    Bian S; Li L; Wang Z; Cui L; Xu Y; Guan K; Zhao B
    Front Public Health; 2022; 10():878081. PubMed ID: 35655467
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anaphylactic Reactions to COVID-19 Vaccines: An Updated Assessment Based on Pharmacovigilance Data.
    Boufidou F; Hatziantoniou S; Theodoridou K; Maltezou HC; Vasileiou K; Anastassopoulou C; Medić S; Tsakris A
    Vaccines (Basel); 2023 Mar; 11(3):. PubMed ID: 36992197
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of Self-reported High-Risk Allergy History With Allergy Symptoms After COVID-19 Vaccination.
    Li L; Robinson LB; Patel R; Landman AB; Fu X; Shenoy ES; Hashimoto DM; Banerji A; Wickner PG; Samarakoon U; Mancini CM; Zhang Y; Blumenthal KG
    JAMA Netw Open; 2021 Oct; 4(10):e2131034. PubMed ID: 34698847
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Allergy to COVID-19 vaccines: A current update.
    Cabanillas B; Novak N
    Allergol Int; 2021 Jul; 70(3):313-318. PubMed ID: 33962863
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A naturally hypersensitive porcine model may help understand the mechanism of COVID-19 mRNA vaccine-induced rare (pseudo) allergic reactions: complement activation as a possible contributing factor.
    Dézsi L; Mészáros T; Kozma G; H-Velkei M; Oláh CZ; Szabó M; Patkó Z; Fülöp T; Hennies M; Szebeni M; Barta BA; Merkely B; Radovits T; Szebeni J
    Geroscience; 2022 Apr; 44(2):597-618. PubMed ID: 35146583
    [TBL] [Abstract][Full Text] [Related]  

  • 27. mRNA COVID-19 Vaccine Anaphylaxis: Epidemiology, Risk Factors, and Evaluation.
    Jaggers J; Wolfson AR
    Curr Allergy Asthma Rep; 2023 Mar; 23(3):195-200. PubMed ID: 36689047
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The adverse reactions to vaccines practice parameter 10 years on-what have we learned?
    Kelso JM
    Ann Allergy Asthma Immunol; 2022 Jul; 129(1):35-39. PubMed ID: 35101646
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Practical handling of allergic reactions to COVID-19 vaccines: A position paper from German and Austrian Allergy Societies AeDA, DGAKI, GPA and ÖGAI.
    Klimek L; Bergmann KC; Brehler R; Pfützner W; Zuberbier T; Hartmann K; Jakob T; Novak N; Ring J; Merk H; Hamelmann E; Ankermann T; Schmidt S; Untersmayr E; Hötzenecker W; Jensen-Jarolim E; Brockow K; Mahler V; Worm M
    Allergo J Int; 2021; 30(3):79-95. PubMed ID: 33898162
    [TBL] [Abstract][Full Text] [Related]  

  • 30. COVID-19 mRNA Vaccines Are Generally Safe in the Short Term: A Vaccine Vigilance Real-World Study Says.
    Chen G; Li X; Sun M; Zhou Y; Yin M; Zhao B; Li X
    Front Immunol; 2021; 12():669010. PubMed ID: 34093567
    [TBL] [Abstract][Full Text] [Related]  

  • 31. COVID vaccination can be performed in patients with a history of allergic reactions to the vaccines or their components: experience from a specialist clinic in South Australia.
    Tunbridge M; Perkins G; Lee M; Salehi T; Ryoo D; Kette F; Smith W; Gold M; Le TA; Yuson C; Hissaria P
    Intern Med J; 2022 Nov; 52(11):1884-1890. PubMed ID: 35848521
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Potential mechanisms of anaphylaxis to COVID-19 mRNA vaccines.
    Risma KA; Edwards KM; Hummell DS; Little FF; Norton AE; Stallings A; Wood RA; Milner JD
    J Allergy Clin Immunol; 2021 Jun; 147(6):2075-2082.e2. PubMed ID: 33857566
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anaphylaxis rates associated with COVID-19 vaccines are comparable to those of other vaccines.
    Maltezou HC; Anastassopoulou C; Hatziantoniou S; Poland GA; Tsakris A
    Vaccine; 2022 Jan; 40(2):183-186. PubMed ID: 34863620
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Management of suspected and confirmed COVID-19 (SARS-CoV-2) vaccine hypersensitivity.
    Worm M; Alexiou A; Bauer A; Treudler R; Wurpts G; Dickel H; Buhl T; Müller S; Jung A; Brehler R; Fluhr J; Klimek L; Mülleneisen N; Pfützner W; Raap U; Roeseler S; Schuh S; Timmermann H; Heine G; Wedi B; Brockow K
    Allergy; 2022 Nov; 77(11):3426-3434. PubMed ID: 35722723
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Allergic reactions to COVID-19 vaccines: statement of the Belgian Society for Allergy and Clinical Immunology (BelSACI).
    Tuyls S; Van Der Brempt X; Faber M; Gadisseur R; Dezfoulian B; Schrijvers R; Froidure A;
    Acta Clin Belg; 2022 Jun; 77(3):552-557. PubMed ID: 33792500
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Management of BNT162b2 mRNA COVID-19 vaccine in children aged 5-11 years with allergies, asthma, and immunodeficiency: consensus of the Italian Society of Pediatric Allergy and Immunology (SIAIP).
    Novembre E; Tosca M; Caffarelli C; Calvani M; Cardinale F; Castagnoli R; Chiappini E; Cravidi C; Del Giudice MM; Duse M; Licari A; Manti S; Martelli A; Ricci G; Pingitore G; Marseglia GL
    Ital J Pediatr; 2022 May; 48(1):76. PubMed ID: 35578294
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cutaneous and Allergic reactions due to COVID-19 vaccinations: A review.
    Temiz SA; Abdelmaksoud A; Wollina U; Kutlu O; Dursun R; Patil A; Lotti T; Goldust M; Vestita M
    J Cosmet Dermatol; 2022 Jan; 21(1):4-12. PubMed ID: 34791757
    [TBL] [Abstract][Full Text] [Related]  

  • 38. EAACI statement on the diagnosis, management and prevention of severe allergic reactions to COVID-19 vaccines.
    Sokolowska M; Eiwegger T; Ollert M; Torres MJ; Barber D; Del Giacco S; Jutel M; Nadeau KC; Palomares O; Rabin RL; Riggioni C; Vieths S; Agache I; Shamji MH
    Allergy; 2021 Jun; 76(6):1629-1639. PubMed ID: 33452689
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk stratification through allergy history: single-centre experience of specialized COVID-19 vaccine clinic.
    Lyons D; Murray C; Hannigan S; Sui J; Alamin S; Conlon N; Keogan M; Khalib K; Fitzpatrick C; O'B Hourihane J; Carey M; Edgar JDM
    Clin Exp Immunol; 2022 Aug; 209(2):182-187. PubMed ID: 35753019
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Patients with previous immediate hypersensitivity reactions to polyethylene glycol can safely receive the BNT162b2 mRNA COVID-19 vaccine.
    Hurst M; Jordan A; Capstick J; Brewerton M; Cockroft R; Ingram J
    Intern Med J; 2022 Oct; 52(10):1818-1820. PubMed ID: 36000384
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.